Tumor necrosis factor (TNF) - alpha antagonists (eg, adalimumab, etanercept, golimumab, certolizumab pegol, infliximab, and their biosimilars) reduce the progression of joint damage (see rheumatoid arthritis treatment for more details about TNF inhibitors).